GSK plc ( GLAXF) - Key Metrics
GLAXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.08 | $0.11 | $0.62 | $0.54 |
| 2026Q1 | $1.90 | $0.43 | $0.28 | $0.17 |
| 2025Q4 | $2.14 | $0.16 | $0.52 | $0.38 |
| 2025Q3 | $1.61 | $0.38 | $0.57 | $0.49 |
| 2025Q2 | $1.97 | $0.36 | $0.52 | $0.36 |
GLAXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 167.13% | 43.05 |
| 2026Q1 | 37.02% | 11.98 |
| 2025Q4 | 101.57% | 28.53 |
| 2025Q3 | 44.98% | 10.20 |
| 2025Q2 | 45.46% | 9.44 |
GLAXF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.87% | 0.95% |
| 2026Q1 | 0.84% | 0.78% |
| 2025Q4 | 2.07% | 0.88% |
| 2025Q3 | 3.16% | 1.10% |
| 2025Q2 | 2.65% | 1.19% |
GLAXF
Price: $22.77
Dividend Yield: 3.61%
Payout Ratio: 51.48%
Earnings Per Share: 1.57 USD
P/E Ratio: 16.38
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 101.0 billion
Average Dividend Frequency: 8
Years Paying Dividends: 23
DGR3: 13.82%
DGR5: 6.76%
DGR10: 1.46%
DGR20: 6.10%